Standardizing the Amyloid Frontier: Inside FDA Clearance of MICSI-PET
Dr. Dereck Mush, MD, MBA
Perspectum
Quantitative medical imaging tools to diagnose and monitor metabolic liver diseases.
What they do
Perspectum develops advanced, non-invasive imaging software that measures liver fat, inflammation, and fibrosis from MRI scans. Used by clinical researchers and healthcare providers, the technology offers a precise alternative to liver biopsies for managing metabolic dysfunction-associated steatotic liver disease.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Quantitative metabolic imaging
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- Oxford, UK
- Region
- Europe
- Founded
- 2012
- Total funding
- $135M raised
Notable investors: Oppenheimer Holdings, Blueush, HealthQuest Capital.
Also in Imaging & Diagnostics
Related on The Signal
Dr. Dereck Mush, MD, MBA
Decentralizing the Neuro-ICU: The Clinical Economics of Quantitative Bedside Brain Monitoring
Dr. Dereck Mush, MD, MBA
Point-of-Care Ultrasound Is the Quiet Revolution in Diagnostics
Dr. Dereck Mush, MD, MBA
The $1 Billion Bet on Pre-Symptomatic Medicine: Who Will Own the Longitudinal Baseline?
Dr. Dereck Mush, MD, MBA